Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial

Hesperidin inhibits insulin-induced phosphoinositide 3–kinase/Akt activation in human pre-B cell line NALM-6

(2018) SayedHossein Davoodi et al.   Journal of Cancer Research and Therapeutics

The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity

(2018) Daniela Gentile et al.   PLoS One

The epidemiology of non-alcoholic fatty liver disease

(2017) Stefano Bellentani   LIVER INTERNATIONAL

Hesperidin Supplementation Alleviates Oxidative DNA Damage and Lipid Peroxidation in Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Clinical Trial

(2017) Fatemeh Homayouni et al.   PHYTOTHERAPY RESEARCH

Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

(2016) Mehran Rahimlou et al.   Hepatitis Monthly

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study

(2016) Zahra Yari et al.   INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

(2016) Amedeo Lonardo et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Hesperidin Supplementation Modulates Inflammatory Responses Following Myocardial Infarction

(2015) F. Haidari et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

(2014) Tannaz Eslamparast et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation of PPARγ and abrogation of oxidative stress and inflammation

(2014) Ayman M. Mahmoud   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

(2014) Forouzan Faghihzadeh et al.   NUTRITION RESEARCH

Editorial: Effect of Atorvastatin, Vitamin E and C on Nonalcoholic Fatty Liver Disease: Is the Combination Required?

(2011) Bianca M Arendt et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Citrus Polyphenol Hesperidin Stimulates Production of Nitric Oxide in Endothelial Cells while Improving Endothelial Function and Reducing Inflammatory Markers in Patients with Metabolic Syndrome

(2011) Stefano Rizza et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Citrus flavonoids repress the mRNA for stearoyl-CoA desaturase, a key enzyme in lipid synthesis and obesity control, in rat primary hepatocytes

(2011) LaNita A Nichols et al.   Lipids in Health and Disease

Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity

(2010) Piia Simonen et al.   JOURNAL OF HEPATOLOGY

The Citrus Flavonoids Hesperidin and Naringin Do Not Affect Serum Cholesterol in Moderately Hypercholesterolemic Men and Women

(2010) Isabelle Demonty et al.   JOURNAL OF NUTRITION

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

(2009) Kittichai Promrat et al.   HEPATOLOGY